SABBY 13G RTRX 02.12.13

Company

Travere Therapeutics, Inc.

Filed

February 15, 2013

Accession Number

0001535610-13-000029

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →